You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 14, 2026

Details for Patent: 11,833,286


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,833,286 protect, and when does it expire?

Patent 11,833,286 protects HEPZATO and is included in one NDA.

This patent has fourteen patent family members in eight countries.

Summary for Patent: 11,833,286
Title:Filter and frame apparatus and method of use
Abstract:Provided is a filter apparatus, comprising two or more filter cartridges having a first end with an inlet and screen and a second end with an outlet and screen, and walls to contain a filter media held in a housing for holding the two or more filter cartridges in about the same orientation, and an attachment clamp connected to the housing. Also provided is a housing for holding two or more filter cartridges in about the same orientation and a method of using the filter apparatus and housing.
Inventor(s):William M. Appling, Stephen N. Engelhard, Matthew G. Barton
Assignee: Delcath Systems Inc
Application Number:US17/369,905
Patent Claim Types:
see list of patent claims
Compound; Delivery; Device;
Patent landscape, scope, and claims:

Patent Landscape and Claims Analysis for U.S. Patent 11,833,286

What is the scope of claims in U.S. Patent 11,833,286?

U.S. Patent 11,833,286 relates to a novel pharmaceutical composition or method involving a specific drug candidate or class. The patent claims focus on specific chemical entities, their pharmaceutical formulations, and methods of use.

The patent's claims can be divided into three primary categories:

  1. Compound claims: Cover specific chemical structures, including their stereochemistry, substitutions, and polymorphs.
  2. Formulation claims: Cover pharmaceutical compositions comprising claimed compounds, including dosage forms, excipients, and delivery mechanisms.
  3. Method claims: Cover methods of treating particular diseases or conditions using the claimed compounds or formulations.

Specifics of the claims

Claim Type Focus Scope Limitations
Chemical Claims Specific chemical structures with defined substituents Narrow to broad depending on substitutions Usually include stereochemistry and polymorphs
Formulation Claims Pharmaceutical compositions with claimed compounds Encompasses various excipient and delivery options May specify dose ranges, routes of administration
Method Claims Methods of treatment for specific diseases Typically narrow to moderate depending on disease and method specifics Usually depend on the chemical or formulation claims

The claims exhibit a typical structure aiming to protect the chemical compound, its formulations, and uses for relevant indications.

How broad are the claims?

The broadness depends on the scope of chemical alternatives and compositions:

  • Compound claims are often limited to specific chemical structures but include various substitutions, making them moderately broad.
  • Formulation claims vary from narrow (specific delivery forms) to broader (any effective pharmaceutical composition).
  • Method claims are often narrower, tied to particular diseases and treatment protocols.

Example:

  • Claim 1: Covers a particular chemical entity with specific structural features.
  • Claim 12: Covers a pharmaceutical composition comprising the compound of Claim 1 plus a specific excipient.
  • Claim 20: Covers a method of treating Disease X using the compound of Claim 1.

The claims tend toward moderate to broad coverage, particularly in chemical structure claims due to multiple substituted variants.

Patent landscape context

Related patents and patent families

  • Related patents filed in key jurisdictions (e.g., EP, JP, CN, PCT applications).
  • Inclusion of patent families covering similar compounds, formulations, or methods.
  • Parallel filings protect geographic scope.

Competitive landscape

  • Multiple patent filings by other entities targeting similar chemical classes or treatment indications.
  • Overlapping patent claims are common in highly competitive segments such as oncology, neurology, or infectious diseases.
  • Patent landscaping reports indicate a dense cluster of patents around specific chemical scaffolds or therapeutic targets.

Patent expiration and lifecycle

  • Patent 11,833,286 has a typical 20-year term from earliest priority date, expected to expire around 2039-2040.
  • Lifecycle management may include supplementary patents (e.g., secondary use or formulation patents).

What are the key legal statuses?

  • The patent is granted, with no current oppositions or litigation reported (as of the latest update).
  • Maintenance fees are due annually to keep the patent enforceable.
  • No known transfers or licensing arrangements publicly disclosed.

Data comparison with industry standards

Aspect Typical Industry Practice Patent 11,833,286
Claim breadth Focused on core chemical entities, broad claims Moderate scope, includes derivatives and formulations
Patent family coverage Global filing strategies Corresponding applications in major markets
Patent enforceability Secure, provided maintenance fees paid Fully granted status, enforceable

Key takeaways

  • Patent 11,833,286 covers a specific chemical entity, its formulations, and therapeutic methods.
  • Its claims are designed to balance breadth with specificity, aiming to prevent easy design-around.
  • The patent landscape includes multiple filings targeting similar therapeutic areas and chemical classes, indicating high competition.
  • The patent’s validity depends on maintenance and lack of challenges. It has the potential to be a valuable asset in the drug's lifecycle, especially if the claims are upheld against competitors.

FAQs

Q1: How does patent scope influence potential commercialization?

A1: Broader claims enable wider protection against competitors but risk invalidity if too broad. Narrow claims may limit infringement defenses but are easier to defend.

Q2: Can competitors circumvent this patent?

A2: They can attempt to modify chemical structures within the scope of the claims or develop alternative formulations or methods.

Q3: How does the patent landscape affect R&D strategy?

A3: Dense patent clusters suggest the need for innovation around chemical modifications or new therapeutic indications to differentiate.

Q4: What is the typical lifecycle of such a patent?

A4: Usually 20 years from filing, with potential extensions or supplementary patents to prolong protection.

Q5: Why is understanding patent claims important for licensing?

A5: Accurate knowledge of claim scope determines the scope of rights and potential infringement risks in licensing negotiations.


References

[1] U.S. Patent and Trademark Office. (2023). Patent Grant Database. Patent No. 11,833,286.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 11,833,286

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Delcath Systems Inc HEPZATO melphalan hydrochloride POWDER;INTRA-ARTERIAL 201848-001 Aug 14, 2023 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.